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Two venom peptides, CPY-Pl1 (EU000528) and CPY-Fe1
(EU000529), characterized from the vermivorous marine snails
Conus planorbis and Conus ferrugineus, define a new class of
conopeptides, the conopeptide Y (CPY) family. The peptides have
no disulfide cross-links and are 30 amino acids long; the high con-
tent of tyrosine is unprecedented for any native gene product. The
CPYpeptideswerechemically synthesizedandshowntobebiolog-
ically active upon injection into both mice and Caenorhabditis
elegans; activity onmammalianKv1 channel isoformswas demon-
stratedusing anoocyte heterologous expression system, and selec-
tivity for Kv1.6 was found. NMR spectroscopy revealed that the
peptideswereunstructured in aqueous solution; however, a helical
region including residues 12–18 for one peptide, CPY-Pl1, formed
in trifluoroethanol buffer. Clones obtained from cDNA of both
species encoded prepropeptide precursors that shared a unique
signal sequence, indicating that these peptides are encoded by a
novel gene family. This is the first report of tyrosine-rich bioactive
peptides inConus venom.
The venom of marine gastropods in the genus Conus has
yielded numerous structurally and functionally diverse peptidic
components (1). The increasing variety of bioactive peptides
identified in cone snail venoms has provided insight into the
seemingly endless variety of directions taken by Conus species
in evolving neuroactive molecules to suit their diverse biologi-
cal purposes.
The bioactive peptides in Conus (“conopeptides”) are classi-
fied into two broad groups: the non-disulfide-rich and the dis-
ulfide-rich (1). The latter are conventionally called conotoxins.
The non-disulfide-rich class includes conopeptides with no
cysteines (contulakins (2), conantokins (3), and conorfamides
(4)) and conopeptideswith two cysteines forming a single disul-
fide bond (conopressins (5) and contryphans (6)). The
conopeptides that compose the disulfide-rich class have two or
more disulfide bonds (1); among themajor classes of molecular
targets identified for these structurally diverse conopeptides
are members of the voltage-gated and ligand-gated ion channel
superfamilies.
In this work, we present the discovery and characterization
of a novel class of peptides, whichwe designate the conopeptide
Y (CPY)2 family, from the marine snails Conus planorbis and
Conus ferrugineus (see Fig. 1). Both of these species belong to a
distinct clade of Conus (7, 8). The first two peptides (9) belong-
ing to the CPY family have a high frequency of tyrosine resi-
dues, in addition to basic and hydrophobic residues. The pep-
tides are shown to be biologically active when injected into
mouse and the nematode Caenorhabditis elegans. Activity on
the Kv1 channel subfamily is demonstrated, and the subtype
selectively within the subfamily is defined.
EXPERIMENTAL PROCEDURES
Extraction and Fractionation of C. planorbis Venom—Snails
were collected in Cebu and Marinduque Islands, Philippines,
and dissected. Venom was pressed out of freshly dissected
venom ducts that were kept on ice. Venom pooled from several
snails was lyophilized and stored at70 °C. A 500-mg portion
was resuspended in 35 ml of 30% acetonitrile and 0.2% triflu-
oroacetic acid using a Vortex mixer for 2 1min with an inter-
val of 5 min on ice. The mixture was sonicated using a Branson
LS-75 probe for 3 0.5 min on ice with 1-min rest periods, and
the sediment was pelleted in a Beckman Avanti centrifuge with
an F650 rotor. Centrifugation was done for 30 min at 37,500
g. The supernatant was diluted with 0.1% trifluoroacetic acid,
centrifuged again to remove all residual particles, and applied to
a preparative Vydac C18 high pressure liquid chromatography
(HPLC) column (2.5  25 cm). Venom peptides were eluted
from the column with a linear gradient of 4.5–90% acetonitrile
and 0.1% trifluoroacetic acid at 0.9% acetonitrile/min. The flow
rate was 20 ml/min, and the absorbance of the eluate was mon-
itored at 220 nm. An analytical Vydac C18 HPLC column (4.6
250 mm) with a linear gradient at 0.45% acetonitrile/min in
0.1% trifluoroacetic acid at a flow rate of 1 ml/min was used for
subfractionation.
Bioassay of HPLC Fractions on Nereis virens—Specimens
(usually within 10–16 cm long) ofN. virenswere maintained in
seawater at 0–4 °C in a cold room. During injections, the
worms were taken outside the cold room in individual beakers
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containing cold seawater. The temperature was maintained
close to 4 °C by keeping the beakers immersed in iced water.
Each worm was laid out on a block of Styrofoam right before
injection and returned to cold seawater within a few seconds
after injection. Lyophilized samples resuspended in 10–12l of
normal saline solution were injected using an insulin syringe at
the anterior end of the worm. A needle lid with the tip cut off
was used to obtain a consistent depth of needle puncture of
1.5 mm. The initial effects of injections were evaluated by
transferring the worms to seawater at room temperature for
5–15 s at1 h after injection. These were observed side by side
with saline-injected controls continuously for at least 4 h and
checked every day for at least 2 weeks.
Characterization of Peptides—Samples were completely
reducedwith 10mMdithiothreitol at 65 °C for 15min and com-
pletely alkylated using 0.7% 4-vinylpyridine for 20 min in the
dark at room temperature. Alkylation reactions were diluted
10-fold with 0.1% trifluoroacetic acid and fractionated in an
analytical C18 HPLC column. Elution was done with a linear
gradient of 1.8% acetonitrile/min in 0.1% trifluoroacetic acid at
a flow rate of 1 ml/min.
Peptide sequencing by Edman degradation chemistry was
done on alkylated samples after HPLC purification. Uncertain
readings of C-terminal residues were verified by sequencing of
fragments obtained after endopeptidase digestion with Arg-C.
The reaction conditions for enzyme digestion were as recom-
mended by the supplier (Roche Diagnostics).
Mass determinations on both native and synthetic peptides
were done by matrix-assisted laser desorption ionization or
electrospray ionization mass spectrometry at the University of
UtahMass Spectrometry and Proteomic Core Facility, the Salk
Institute Peptide Biology Lab, and The University of Queens-
land Institute for Molecular Bioscience.
Chemical Synthesis and Purification of CPY-Pl1 and
CPY-Fe1—CPY-Pl1 and CPY-Fe1 were synthesized on an ABI
433 peptide synthesizer (Applied Biosystems, Foster City, CA)
following the FastMoc chemistry procedure from ABI. Stand-
ard protecting groups for the amino acid side chains were used.
The cleaved peptide was further purified by HPLC on a semi-
preparative C18 column with a linear gradient of 0.18% aceto-
nitrile/min in 0.1% trifluoroacetic acid. The flow rate was 2.5
ml/min, and absorbance at 220 and 280 nm was monitored.
NMR Spectroscopy—Samples for 1H NMR measurements
contained 2 mM peptide in 90% H2O and 10% D2O (v/v) at
pH 3 or 20% TFE, 80% H2O, and 10% D2O. Spectra were
recorded at 288–298 K on a Bruker ARX-600 spectrometer
equippedwith a shielded gradient unit. Two-dimensionalNMR
spectra were recorded in phase-sensitivemode using time-pro-
portional phase incrementation for quadrature detection in the
t1 dimension as described previously for other disulfide-rich
peptides (10, 11).
Spectra were processed on a Silicon Graphics Indigo Work-
station using XWINNMR software (Bruker). The t1 dimension
was zero-filled to 1024 real data points, and 90° phase-shifted
sine bell window functions were applied prior to Fourier trans-
formation. Chemical shifts were referenced to internal 2,2-di-
methyl-2-silapentane-5-sulfonate. NMR spectral assignments
for CPY-Pl1 were made using established techniques (12).
Bioassay of Synthetic Samples in Mice and C. elegans—In-
tracranial injections were administered to mice (Swiss Web-
ster) that were 15–17 days old. Peptide samples in HPLC solu-
tions were lyophilized, resuspended in 12 l of normal saline
solution, and administered intracranially tomice using an insu-
lin syringe. The peptide-injected mice were observed side by
side with saline-injected controls continuously for 2–4 h and
checked the next day. Microinjection of peptide samples into
the pseudocoelomic region of the nematode C. elegans was
done as described (13).
Electrophysiology—The Xenopus oocyte expression sys-
tem was used to study the effect of the CPY peptides on K
and Na channels (14) and the N-methyl-D-aspartate recep-
tor (15). In K channel assays, oocytes were treated, and
channels were expressed as described (16). Whole cell cur-
rents were recorded at room temperature (19–22 °C) under
two-electrode voltage-clamp control using an 0C-725C
amplifier (Warner Instruments, Hamden, CT) or a Turbo-
Tec amplifier (npi electronic GmbH, Tamm, Germany).
Current records were low pass-filtered at 3 kHz and sampled
at 10 or 1 kHz (3 db) and sampled at 4 kHz. The bath
solution was normal frog Ringer’s (17) containing 115 mM
NaCl, 2.5 mM KCl, 1.8 mM CaCl2, and 10 mM Hepes-NaOH
(pH 7.2). Bovine serum albumin (0.1 mg/ml) was added to
the bath solution in all the dose-response experiments. The
IC50 values for block of the Kv1.6 channel were calculated
from the peak currents at a test potential of 20 or 0 mV
according to IC50  fc/(1  fc)  [Tx], where fc is the frac-
tional current and [Tx] is the toxin concentration.
Cloning—Total RNA preparations from a single duct each of
C. planorbis and C. ferrugineus (Fig. 1) were obtained using the
Qiagen RNeasy mini prep protocol for isolation of total RNA
from animal tissues. Each RNA preparation (4.5 g for C. pl-
anorbis and 5.1 g for C. ferrugineus) was used in cDNA syn-
thesis (18). Degenerate primers derived from CPY-Pl1 and
CPY-Fe1 sequences were utilized in 3-RACE (18) and
5-RACE (SMART RACE, Clontech) experiments on C. pl-
anorbis cDNA. Oligonucleotide primers designed from the sig-
nal sequence identified for CPY-Pl1 were used in 3-RACE (18)
on C. planorbis and C. ferrugineus cDNAs. All PCR runs were
done in a PTC-200 Peltier thermal cycler (MJ Research, Inc.,
Waltham, MA) using high fidelity Platinum Taq DNA poly-
merase (Invitrogen). The TOPO TA cloning kit (Invitrogen)
was used for all transformations. DNA sequencing was done at
the University of Utah Huntsman Cancer Institute Protein/
DNA Core Facility using samples prepared following the Qia-
gen mini prep kit protocol.
RESULTS
Isolation of CPY Peptides from the Venom of C. planorbis
(9)—Crude C. planorbis venom was fractionated by HPLC as
described under “Experimental Procedures.” Biological
activity on the marine worm N. virens was used to identify
active fractions from the preparative HPLC column (Fig. 2A)
and to guide further subfractionation (Fig. 2B). Aliquots of
the fractions and subfractions were pooled, lyophilized, and
assayed on N. virens as described under “Experimental Pro-
cedures”; if a pool showed bioactivity as described below,
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individual fractions were assayed. The fraction indicated in
Fig. 2A gave characteristic symptoms when injected into
N. virens. Worms that had not been injected or those
injected with the control solution (normal saline solution)
would move in energetic S-like patterns when transferred to
seawater at room temperature. In contrast, affected worms
did not move in S-like patterns, but would just glide or move
very slowly. All injected worms were moved back to cold
seawater after 5–15 s of observation in seawater at room
temperature; worms that mani-
fested the initial symptomatology
eventually became weak or died in
1–5 days. Uninjected and control
worms survived for months.
The subfractions in Fig. 2B were
assayed individually, and one peak
exhibited the activity on N. virens
described above. The active peak in
Fig. 2B was completely reduced and
alkylated as described under
“Experimental Procedures.” The
reduced and alkylated material was
fractionated by HPLC (Fig. 2C); the
earlier eluting peak indicated by the
arrow is CPY-Pl1, and the later elut-
ing peak is CPY-Fe1.
The peptides were sequenced
using standard Edman methods.
The peptide sequences obtained
had a most striking sequence fea-
ture: an unusually high frequency of
tyrosine residues, in addition to
basic and hydrophobic residues.
The sequences of the two peptides
are shown in Fig. 3; the monoiso-
topic masses of 4092.1 and 4040.1
Da that were obtained corre-
sponded to the respective calculated
masses for CPY-Pl1 and CPY-Fe1.
Sixteen of the 30 residues are iden-
tical in the two peptides, including
five tyrosine residues.
The high content of tyrosine in
CPY-Pl1 and CPY-Fe1 is reminis-
cent of the vertebrate neuropeptide
Y family (see Fig. 3); we refer to
these peptides as the conopeptide Y
or CPY family.We propose to name
these CPY family peptides from
Conus venoms using the following
nomenclature. The individual pep-
tides will be indicated by the first
two letters of the species name, fol-
lowed by a number representing the
numerical sequence of peptides that
belong to this family from each spe-
cies. The two Tyr-rich peptides iso-
lated fromwhat was presumed to be
C. planorbis venom are referred to as CPY-Fe1 (Fe for ferrug-
ineus) and CPY-Pl1 (Pl for planorbis). Results from cloning,
described below, suggest that both C. ferrugineus and C. pl-
anorbis venoms were present in the sample labeled “pooled
C. planorbis venom” that was used. Because of the close resem-
blance of shells of the two species (Fig. 1), the mistaken identi-
fication of one species for the other was highly probable during
the period that specimens were accumulated to prepare the
pooled crude venom that yielded the purified peptides.
FIGURE 1. Shells of C. planorbis (upper row) and C. ferrugineus (lower row). The bar represents 1 cm. Note
that freshly collected specimens of C. ferrugineus could easily be mistaken for specimens of C. planorbis (pho-
tograph by Kerry S. Matz).
CPY Conopeptide Family
23028 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283•NUMBER 34•AUGUST 22, 2008
 at UQ Library on October 9, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Chemical Synthesis of CPY Peptides—The chemical synthesis
of the CPY peptides was carried out as described under “Exper-
imental Procedures.” The HPLC chromatograms for the coelu-
tion of synthetic CPY-Fe1 and CPY-Pl1 with the respective
native samples are shown in Fig. 4 (upper and lower) (9). The
isotopic peaks in the mass spectra of both synthetic peptides
matched those in the spectra of the native samples.
NMR Spectroscopy—The secondary shifts of CPY-Pl1 in
aqueous solution and in 20%TFE are shown in Fig. 5. In general,
analysis of H chemical shifts of peptides can provide a strong
indication of the type of secondary structure present. For CPY-
Pl1 in aqueous solution, the chemical shifts suggest that no
regular secondary structure is present based on the lack of
stretches of consistent positive or negative secondary shifts.
However, in the presence ofTFE, a series of significant (i.e.0.1
ppm) negative deviations from random coil shifts between
residues 12 and 18 suggest the presence of helical structure
in this region. TFE is commonly reported to stabilize helical
structures in peptides having an intrinsic helical tendency,
and this appears to be the case for CPY-Pl1.
Bioassay of CPY-Fe1 Using Mice and C. elegans—Mice were
injected intracranially with CPY-Fe1. Mice injected with 0.7
nmol of peptide/g ofmouse exhibited onlymild symptoms such
as slightly more than usual grooming, climbing, or hyperactiv-
ity. An attempt to elicit more definitive symptomatology by
dropping the metal lid onto the cage, thereby creating a loud
acoustic input, caused a 30-s seizure in a mouse injected with
1.5 nmol of peptide/g of mouse. A surprising effect was elic-
ited when one peptide-injected mouse was accidentally
dropped while being transferred between two cages; not only
was a seizure elicited, but death occurred within 10–15 s after
the seizure was initiated. The seizures were observed within
2–3 min after the drop. Thus, we routinely carried out a test
referred to as “the mouse-drop assay” after all succeeding
mouse intracranial injections of the CPY peptides. Injected
mice were dropped from a height of1.5 ft onto the cage bot-
tom starting at 3–5 min after injection. This was repeated
every 5–10 min up to 30 min after injection. The seizure
response to the mouse drop was usually observed after the first
drop. No symptoms were observed in normal saline solution-
injected controls or unaffectedmice, even after four to six drops
within the 30-min period after injection. Both peptides induced
seizures with the mouse-drop assay. The dose response was
determined for theCPY-Fe1 peptide.At a dose of 5 nmol,50%
of the mice responded withmild to moderate seizures.With 20
nmol injected per mouse, most of the mice developed severe
seizures and died.
Microinjections in C. elegans were made at a dose of 10
pmol of CPY-Fe1/worm. Partial paralysis, which lasted for20
min,was observed in four of fourworms injected. In three of the
four worms, paralysis occurred from themidsection to the pos-
terior end; the fourth worm showed paralysis from the midsec-
tion to the anterior end. An initial test on the effect of CPY-Fe1
on the biphasic contractile response of electrically stimu-
lated rat prostatic vas deferens (19) did not show any effect
on both noradrenaline- and ATP-mediated responses with
10 M CPY-Fe1.
Electrophysiology—Initial screening for activity using CPY-
Fe1 on channels expressed in Xenopus oocytes included Kv1.1
to Kv1.6, Kv2.1, Kv3.4, and Nav1.2. In these experiments, the
oocytes used were free of the vitelline membrane (“skinned”)
during the clamping experiments. CPY-Fe1 was found to be
active at 1 M on Kv1.6. When attempts were made to deter-
mine IC50 values with skinned oocytes, evidence for high affin-
ity block of Kv1.6 was obtained for both peptides. However,
there were technical problems using skinned oocytes; these
invariably developed a leak current after a variable length of
time as the measurements were being made. Thus, it was not
feasible to obtain reproducible quantitative measurements
using skinned oocytes.
FIGURE2. IsolationofCPY-Pl1andCPY-Fe1 fromanextractofC. planorbis
venom. A, preparative HPLC chromatogram of the extract showing the
absorbance profile at 220 nm. The preparation of extract and the HPLC
parameters used were as described under “Experimental Procedures.” The
peak indicated by the arrow was potent on the marine worm N. virens as
described under “Results.” B, analytical HPLC chromatogram showing the
absorbance profile of subfractionation of the active peak in A. The arrow
marks the active subfraction. C, analytical HPLC chromatogram of the alkyla-
tion reactionmixture of the active subfraction in B. Peptide sequencing of the
peaks denoted by arrows yielded the sequences for CPY-Pl1 (peak on the left)
and CPY-Fe1 (peak on the right).
FIGURE 3. Alignment of CPY peptides with neuropeptide Y (NPY) (29).
CPY Conopeptide Family
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The dose responses for both CPY-Fe1 and CPY-Pl1 (Fig. 6)
demonstrate that CPY-Pl1 ismore potent on theKv1.6 subtype.
The data shown in Table 1 and Fig. 6 were obtained using
unskinned Xenopus oocytes; the kinetics were slow and took
tens of minutes to reach equilibrium. Table 1 presents the IC50
values obtained from dose-response experiments in oocytes
expressing Kv1.2 to Kv1.6. CPY-Pl1 is more active than CPY-
Fe1 on both Kv1.2 (15-fold) and
Kv1.6 (50-fold). In further assays
using unskinned oocytes, CPY-Pl1
(1 M) inhibited 15% of the
N-methyl-D-aspartate receptor
(NR1–3b/NR2A and NR1–3b/
NR2B) activity and 30% of the
Nav1.2 activity.
Molecular Cloning: Definition of
the CPY Family—A cDNA library
made from C. planorbis venom
ducts was used to identify the pre-
cursors of the CPY peptides. The
predicted open reading frame
including signal sequence, propep-
tide, andmature peptide is shown in
Fig. 7. The cleavage site between the
signal peptide, MMSKLGVVLFV-
FLLLLPLAAP, and the propeptide
was predicted through the SignalP
3.0 server (www.cbs.dtu.dk/services/
SignalP/).
Initial 3-RACE experiments uti-
lizing C. planorbis cDNA and oligo-
nucleotide primers derived from
both peptides yielded clones (7/7)
for CPY-Pl1 but no clones for CPY-
Fe1. Clones (6/6) obtained in
5-RACE experiments for both CPY
peptides on C. planorbis cDNA
using primers from both peptides
gave the CPY-Pl1 precursor even
with the primer derived from CPY-
Fe1, which has a region homologous to the primer derived from
CPY-Pl1. A 3-RACE experiment on C. planorbis cDNA utiliz-
ing oligonucleotide primers derived from the signal sequence
gave CPY-Pl1 clones (7/7) up to the poly(A) tail. A screen for
CPY peptides in C. ferrugineus cDNA using one of the primers
derived from the signal sequence and the poly(T)-containing
QT primer (18) gave clones (4/4) for CPY-Fe1.
The signal and propeptide sequences are completely shared
by the two peptides up to the nucleotide level. Sixteen (Fig. 7) of
the 30 residues of the mature peptide are also shared up to the
nucleotide level. There is 91% homology in the 3-untranslated
regions of CPY-Fe1 (EU000529) and CPY-Pl1 (EU000528). The
unique signal sequence revealed from clones encoding precur-
sors of these peptides defines a new gene family of conopep-
tides, which we refer to as the conopeptide Y or CPY family.
DISCUSSION
The peptides characterized in this study are unusual in their
high content of tyrosine, normally an uncommon amino acid.
MostConus venompeptides are stabilized bymultiple disulfide
bonds. As a rule, the Conus venom peptides that lack disulfide
cross-links tend to be smaller in size than the disulfide-rich
conotoxins. The CPY peptides that are characterized here are
the longest conopeptides without disulfides shown to be bio-
logically active. In addition to the high tyrosine content, these
FIGURE 4. Coelution (right panels) of CPY-Fe1 (upper panels) and CPY-Pl1 (lower panels) that were iso-
lated from the venom (left panels) and the corresponding synthetic peptides (middle panels). HPLC was
performed in an analytical C18 columnusing a gradient of 0.18% acetonitrile/min in 0.1% trifluoroacetic acid in
a Waters Millenium HPLC system with an autosampler, and data were transcribed into Prism.
FIGURE 5. Chemical shift analysis of CPY-Pl1. The secondary shifts were
determined by subtracting the random coil shifts (30) from the experimental
H shifts of CPY-Pl1. Values in aqueous solution are shown with black bars,
and those in the presence of 20% TFEwithwhite bars. The dashed line at0.1
ppm indicates the threshold for significant deviations from the random coil.
The helical region in the presence of TFE from residues 12 to 18 is highlighted
schematically. The predicted helical region (NNPREDICT) is shownwith a gray
bar andoverlaps significantlywith thehelical regiondeduced from the chem-
ical shifts.
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peptides are enriched in arginine and large hydrophobic resi-
dues (Phe, Leu, and Ile); in CPY-Pl1, these five amino acids
account for70% of the total.
Both CPY-Fe1 and CPY-Pl1 were isolated (9) from a batch of
venom that had been assumed to have come from specimens of
C. planorbis. The cloning results strongly indicated, however,
that one of the CPY peptides that was isolated from the pooled
venom, CPY-Fe1, could be cloned only from cDNA derived
from a C. ferrugineus venom duct. Correspondingly, only CPY-
Pl1 clones (20/20) were detected from C. planorbis cDNA. As
shown in Fig. 1, there are shells ofC. ferrugineus orC. planorbis
that could easily be confused as one or the other; indeed, the
precise taxonomy of the complex of species related to C. pl-
anorbis remains unresolved. Each cDNA preparation was
obtained from a single venom duct of each species; thus, the
cloning results seem more reliable than those obtained by
extraction from venom pooled from 100 or so specimens.
We have demonstrated that these peptides are antagonists of
voltage-gated K channels belonging to the Kv1 subfamily.
Both of the peptides characterized exhibited selectivity for
Kv1.6 among the Kv1 subfamily channels tested, with CPY-Pl1
showing submicromolar affinity (IC50  0.17 M). Conopep-
tides derived from venoms of worm-hunting Conus species
(such as C. planorbis) generally tend to show lower affinity for
mammalian homologs than do the corresponding conopep-
tides fromvenoms of fish-hunting cone snails; thus, the data are
not inconsistent with the native target of this peptide being the
Kv1.6 homolog in the polychaete worm prey of C. planorbis.
Another possibility is that an even higher affinity K channel
target will be found in mammalian systems as well as in
polychaetes. The data in Table 1 suggesting that these peptides
have a higher affinity for Kv1.6 but also target Kv1.2 with lower
affinity raise the possibility that the native target is a hetero-
meric combination of subunits (such as an interface between
Kv1.6 and Kv1.2). Thus, selectivity for a heteromeric Kv1 target
that hasmore than one type of subunit is also a viable possibility
that needs to be considered.
The variable onset of leak currents in skinned oocytes sug-
gests that, in addition to the K channel blocking activity, the
CPY peptides may also be membrane-active. Because these are
hydrophobic peptides, the possibility that they can insert into
membranes to form pores or destabilize the oocytemembranes
in some other manner could explain the unpredictable leak
observed; in contrast, the unskinned oocytes remained stable
enough so that the reliable dose-response data shown in Fig. 6
and Table 1 could be obtained. A small peptide lacking disul-
fides that inhibited voltage-gated K channels was reported
previously fromConusmonile; the subfamily selectivity was not
reported (20). The CPY peptide that has been most well char-
acterized, CPY-Pl1, is highly selective for theKv1.6 subtype. It is
notable that CPY-Pl1 is 18-fold more potent on Kv1.6 than
pl14a, a disulfide-rich peptide that was isolated previously from
the same venom (9, 21).
Conus species have a structurally diverse group of peptides
targeted to the Kv1 subfamily; the first such peptide character-
ized was -conotoxin PVIIA (22), from the venom of the fish-
hunting cone snail Conus purpurascens; this peptide has three
disulfide bonds and belongs to the O-gene superfamily. Sur-
prisingly, when Kv1 channel-targeted peptides from two other
clades of fish-hunting coneswere elucidated, peptides structur-
ally unrelated to -conotoxin PVIIA were found: M-cono-
toxin RIIIK (23) from Conus radiatus also has three disulfide
bonds but belongs to the M-gene superfamily, and conkunit-
FIGURE 6. Activity of CPY-Fe1 and CPY Pl1 on the Kv1.6 channel. A, the
horizontal bars correspond to 50ms, and the vertical bars correspond to 1A.
B, each data point is an average of responses obtained from at least three
oocytes as described under “Experimental Procedures,” and the dose-re-
sponse curvesweregeneratedusingPrism. The IC50 for CPY-Fe1 is 8.8M, and
that for CPY-Pl1 is 170 nM.
FIGURE 7. CPY-Pl1 and CPY-Fe1 precursors. Complete homology between
the two clones occurs in the signal sequence and propeptide regions; 91%
homology is observed in the 3-untranslated regions (not shown). The resi-
dues sharedby thematurepeptides are inboldface. Polymorphismwas found
in the CPY-Pl1 clones at the sixth residue from the C terminus of the mature
peptide where isoleucine was substituted with valine in 30% of the
sequences obtained; thepeptidewith the isoleucine residuewas identified in
the venom (Fig. 3) and subsequently synthesized.
TABLE 1
Activity of CPY peptides onmammalian Kv1 isoforms expressed in
Xenopus oocytes
Peptide IC50 (95% confidence interval)Kv1.2 Kv1.3 Kv1.4 Kv1.5 Kv1.6
M
CPY-Fe1 30 50 50 50 8.8 (6.5–12.0)
CPY-Pl1 2.0 (1.0–3.9) 50 50 5 0.17 (0.16–0.19)
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zin-S1 (24, 25) is a Kunitz domain K channel inhibitor from
Conus striatus. The investigation of C. planorbis venom
revealed not only K channel-targeted peptides unrelated to
the three classes above but also twodifferent toxins unrelated to
each other that both preferentially target Kv1.6: J-conotoxin
PlXIVA, a peptide with two disulfide bonds and previously
called pl14a (9, 21), and CPY-Pl1, the peptide characterized in
this study. It is not unprecedented for venom from one species
to contain unrelated peptides that antagonize the same ion
channel complex. It has been previously shown that different
peptides antagonize the same nicotinic receptor subtype in
C. purpurascens (26, 27) and Conus imperialis (28) venoms. In
both cases, the peptides were structurally unrelated and were
subsequently shown to target different pharmacological sites
on the same receptor complex. This appears to be part of the
sophisticated combination drug therapy strategy that cone
snails employ for prey paralysis. We speculate that the natural
prey of C. planorbis has a Kv1.6-like Shaker-type K channel
thatmay be an importantmolecular target in the snail’s strategy
for prey capture.
Multiple disulfide cross-links presumably stabilize most
Conus peptides once they are injected into the body of the tar-
geted animal. Because the CPY peptides are unstructured in
aqueous solution, they would appear to be subject to rapid pro-
teolytic degradation. However, a significant number of Conus
peptide toxins may target axons right at the site of injection; in
the case of fish-hunting cone snails, K channel blockers are
part of the “lightning-strike cabal” of toxins that cause amassive
depolarization of axons in the immediate vicinity of the injec-
tion site, which in effect rapidly immobilizes the prey. It seems
reasonable to speculate that the CPY peptides in C. planorbis
andC. ferrugineus venomsmay play an analogous role in vivo; if
thiswere the case, the peptidesmay act right at the injection site
and, once bound to their targets, would presumably become
much more highly structured and resistant to attack by
proteases.
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